| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | spermatid development | 9.23e-05 | 262 | 58 | 6 | GO:0007286 | |
| GeneOntologyBiologicalProcess | spermatid differentiation | 1.13e-04 | 272 | 58 | 6 | GO:0048515 | |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 1.76e-04 | 186 | 58 | 5 | GO:0030317 | |
| GeneOntologyBiologicalProcess | sperm motility | 2.09e-04 | 193 | 58 | 5 | GO:0097722 | |
| GeneOntologyBiologicalProcess | spermatogenesis | 2.15e-04 | 744 | 58 | 9 | GO:0007283 | |
| GeneOntologyBiologicalProcess | male gamete generation | 2.57e-04 | 762 | 58 | 9 | GO:0048232 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 3.08e-04 | 210 | 58 | 5 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 3.44e-04 | 215 | 58 | 5 | GO:0001539 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 3.44e-04 | 215 | 58 | 5 | GO:0060285 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 3.78e-04 | 803 | 58 | 9 | GO:0030036 | |
| GeneOntologyBiologicalProcess | germ cell development | 3.91e-04 | 482 | 58 | 7 | GO:0007281 | |
| GeneOntologyCellularComponent | muscle thin filament tropomyosin | 8.09e-08 | 4 | 58 | 3 | GO:0005862 | |
| GeneOntologyCellularComponent | striated muscle thin filament | 8.93e-07 | 27 | 58 | 4 | GO:0005865 | |
| GeneOntologyCellularComponent | myofilament | 1.81e-06 | 32 | 58 | 4 | GO:0036379 | |
| GeneOntologyCellularComponent | cell division site | 7.21e-05 | 80 | 58 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | clathrin coat | 5.06e-04 | 56 | 58 | 3 | GO:0030118 | |
| GeneOntologyCellularComponent | cleavage furrow | 6.51e-04 | 61 | 58 | 3 | GO:0032154 | |
| GeneOntologyCellularComponent | actin filament | 7.23e-04 | 146 | 58 | 4 | GO:0005884 | |
| HumanPheno | Intercostal muscle weakness | 7.13e-06 | 11 | 19 | 3 | HP:0004878 | |
| HumanPheno | Neuromuscular dysphagia | 7.13e-06 | 11 | 19 | 3 | HP:0002068 | |
| HumanPheno | Neck muscle weakness | 1.92e-05 | 95 | 19 | 5 | HP:0000467 | |
| HumanPheno | Abnormal morphology of the musculature of the neck | 2.47e-05 | 171 | 19 | 6 | HP:0011006 | |
| HumanPheno | Hypokinesia | 3.89e-05 | 54 | 19 | 4 | HP:0002375 | |
| HumanPheno | Nemaline bodies | 4.11e-05 | 19 | 19 | 3 | HP:0003798 | |
| HumanPheno | Hypoventilation | 4.18e-05 | 55 | 19 | 4 | HP:0002791 | |
| HumanPheno | Generalized limb muscle atrophy | 4.82e-05 | 20 | 19 | 3 | HP:0009055 | |
| HumanPheno | Myopathic facies | 4.82e-05 | 57 | 19 | 4 | HP:0002058 | |
| HumanPheno | Fatiguable weakness of proximal limb muscles | 6.48e-05 | 22 | 19 | 3 | HP:0030200 | |
| HumanPheno | Slender build | 8.61e-05 | 66 | 19 | 4 | HP:0001533 | |
| HumanPheno | Reduced vital capacity | 1.51e-04 | 29 | 19 | 3 | HP:0002792 | |
| HumanPheno | Diminished movement | 2.01e-04 | 82 | 19 | 4 | HP:0002374 | |
| HumanPheno | Muscle fiber cytoplasmatic inclusion bodies | 2.04e-04 | 32 | 19 | 3 | HP:0100303 | |
| HumanPheno | Fetal akinesia sequence | 2.45e-04 | 34 | 19 | 3 | HP:0001989 | |
| HumanPheno | Abnormality of habitus | 2.53e-04 | 87 | 19 | 4 | HP:0010718 | |
| HumanPheno | Respiratory failure | 2.69e-04 | 262 | 19 | 6 | HP:0002878 | |
| HumanPheno | Fatigable weakness of distal limb muscles | 3.64e-04 | 8 | 19 | 2 | HP:0030198 | |
| HumanPheno | Increased muscle lipid content | 3.98e-04 | 40 | 19 | 3 | HP:0009058 | |
| HumanPheno | Muscle fiber inclusion bodies | 3.98e-04 | 40 | 19 | 3 | HP:0100299 | |
| HumanPheno | Respiratory insufficiency due to muscle weakness | 4.84e-04 | 103 | 19 | 4 | HP:0002747 | |
| HumanPheno | Bulbar signs | 5.29e-04 | 44 | 19 | 3 | HP:0002483 | |
| HumanPheno | Facial diplegia | 5.29e-04 | 44 | 19 | 3 | HP:0001349 | |
| HumanPheno | Fatigable weakness of skeletal muscles | 5.66e-04 | 45 | 19 | 3 | HP:0030197 | |
| HumanPheno | Mask-like facies | 6.00e-04 | 109 | 19 | 4 | HP:0000298 | |
| HumanPheno | Neck flexor weakness | 6.04e-04 | 46 | 19 | 3 | HP:0003722 | |
| HumanPheno | Abnormal blood oxygen level | 6.85e-04 | 48 | 19 | 3 | HP:0500165 | |
| HumanPheno | Hypoxemia | 6.85e-04 | 48 | 19 | 3 | HP:0012418 | |
| HumanPheno | Increased variability in muscle fiber diameter | 7.60e-04 | 116 | 19 | 4 | HP:0003557 | |
| HumanPheno | Weakness of muscles of respiration | 7.60e-04 | 116 | 19 | 4 | HP:0004347 | |
| HumanPheno | Central hypoventilation | 8.51e-04 | 12 | 19 | 2 | HP:0007110 | |
| HumanPheno | Impaired mastication | 8.66e-04 | 52 | 19 | 3 | HP:0005216 | |
| HumanPheno | Abnormality of skeletal muscle fiber size | 8.91e-04 | 121 | 19 | 4 | HP:0012084 | |
| HumanPheno | Abnormal blood gas level | 9.16e-04 | 53 | 19 | 3 | HP:0012415 | |
| HumanPheno | Difficulty walking and climbing stairs | 9.68e-04 | 54 | 19 | 3 | HP:0007019 | |
| HumanPheno | Difficulty running | 9.68e-04 | 54 | 19 | 3 | HP:0009046 | |
| HumanPheno | Difficulty walking | 9.68e-04 | 54 | 19 | 3 | HP:0002355 | |
| HumanPheno | Abnormal muscle tissue metabolite concentration | 9.68e-04 | 54 | 19 | 3 | HP:0034370 | |
| HumanPheno | Ankle flexion contracture | 1.08e-03 | 56 | 19 | 3 | HP:0006466 | |
| HumanPheno | Tall stature | 1.12e-03 | 225 | 19 | 5 | HP:0000098 | |
| HumanPheno | Waddling gait | 1.17e-03 | 130 | 19 | 4 | HP:0002515 | |
| HumanPheno | Abnormal blood carbon dioxide level | 1.17e-03 | 14 | 19 | 2 | HP:0500164 | |
| HumanPheno | Hypercapnia | 1.17e-03 | 14 | 19 | 2 | HP:0012416 | |
| HumanPheno | Spinal rigidity | 1.25e-03 | 59 | 19 | 3 | HP:0003306 | |
| HumanPheno | Breech presentation | 1.25e-03 | 59 | 19 | 3 | HP:0001623 | |
| HumanPheno | Ankle contracture | 1.32e-03 | 60 | 19 | 3 | HP:0034677 | |
| HumanPheno | Cor pulmonale | 1.34e-03 | 15 | 19 | 2 | HP:0001648 | |
| HumanPheno | Fatigable weakness of bulbar muscles | 1.38e-03 | 61 | 19 | 3 | HP:0030192 | |
| HumanPheno | Nocturnal hypoventilation | 1.53e-03 | 16 | 19 | 2 | HP:0002877 | |
| HumanPheno | Mildly elevated creatine kinase | 1.59e-03 | 64 | 19 | 3 | HP:0008180 | |
| Domain | TROPOMYOSIN | 1.08e-07 | 4 | 57 | 3 | PS00326 | |
| Domain | Tropomyosin | 1.08e-07 | 4 | 57 | 3 | IPR000533 | |
| Domain | Tropomyosin | 1.08e-07 | 4 | 57 | 3 | PF00261 | |
| Domain | HR1_rho-bd | 5.91e-05 | 25 | 57 | 3 | IPR011072 | |
| Domain | ING | 9.10e-05 | 5 | 57 | 2 | SM01408 | |
| Domain | ING_N_histone_binding | 9.10e-05 | 5 | 57 | 2 | IPR024610 | |
| Domain | ING | 9.10e-05 | 5 | 57 | 2 | PF12998 | |
| Domain | ING_fam | 9.10e-05 | 5 | 57 | 2 | IPR028651 | |
| Domain | FH2 | 9.37e-04 | 15 | 57 | 2 | PS51444 | |
| Domain | FH2_Formin | 9.37e-04 | 15 | 57 | 2 | IPR015425 | |
| Domain | FH2 | 9.37e-04 | 15 | 57 | 2 | PF02181 | |
| Domain | FH2 | 9.37e-04 | 15 | 57 | 2 | SM00498 | |
| Domain | SH3_9 | 1.74e-03 | 78 | 57 | 3 | PF14604 | |
| Domain | Cyclophilin-type_PPIase | 1.85e-03 | 21 | 57 | 2 | IPR024936 | |
| Domain | FCH | 2.03e-03 | 22 | 57 | 2 | PF00611 | |
| Domain | Cyclophilin-like_dom | 2.03e-03 | 22 | 57 | 2 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 2.03e-03 | 22 | 57 | 2 | PS50072 | |
| Domain | Pro_isomerase | 2.03e-03 | 22 | 57 | 2 | PF00160 | |
| Domain | - | 2.03e-03 | 22 | 57 | 2 | 2.40.100.10 | |
| Domain | Cyclophilin-type_PPIase_dom | 2.03e-03 | 22 | 57 | 2 | IPR002130 | |
| Domain | CSA_PPIASE_1 | 2.03e-03 | 22 | 57 | 2 | PS00170 | |
| Domain | FCH_dom | 2.22e-03 | 23 | 57 | 2 | IPR001060 | |
| Domain | tRNA-bd_arm | 2.42e-03 | 24 | 57 | 2 | IPR010978 | |
| Domain | F_BAR | 2.62e-03 | 25 | 57 | 2 | IPR031160 | |
| Domain | F_BAR | 2.62e-03 | 25 | 57 | 2 | PS51741 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 3.33e-06 | 35 | 42 | 4 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 3.74e-06 | 36 | 42 | 4 | M18647 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 4.67e-06 | 38 | 42 | 4 | M39549 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.05e-04 | 83 | 42 | 4 | M8728 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.44e-04 | 90 | 42 | 4 | M835 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 1.51e-04 | 35 | 42 | 3 | MM15114 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 2.79e-04 | 43 | 42 | 3 | M1429 | |
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 3865200 | ||
| Pubmed | A systematic nomenclature for mammalian tropomyosin isoforms. | 1.76e-08 | 4 | 58 | 3 | 25369766 | |
| Pubmed | Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts. | 1.76e-08 | 4 | 58 | 3 | 16765662 | |
| Pubmed | TPM2 TPM3 TPM4 CCNH HSP90B1 GPR19 CENPF KRT77 U2SURP DIAPH3 NOSTRIN NEB TTC3 STK31 | 7.63e-08 | 1442 | 58 | 14 | 35575683 | |
| Pubmed | 8.77e-08 | 6 | 58 | 3 | 23792823 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.32e-07 | 497 | 58 | 9 | 36774506 | |
| Pubmed | 2.58e-07 | 538 | 58 | 9 | 28524877 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPM3 HSP90B1 IGF2R SARS1 STXBP3 CENPF POLA1 U2SURP PPIL4 NOL10 UTP3 GALNT5 TTC3 | 4.90e-07 | 1425 | 58 | 13 | 30948266 |
| Pubmed | Nemaline Myopathy – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 5.24e-07 | 10 | 58 | 3 | 20301465 | |
| Pubmed | 2.07e-06 | 54 | 58 | 4 | 22266860 | ||
| Pubmed | High molecular weight tropomyosins regulate osteoclast cytoskeletal morphology. | 2.73e-06 | 2 | 58 | 2 | 18674650 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 10671526 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22798622 | ||
| Pubmed | Variants in tropomyosins TPM2 and TPM3 causing muscle hypertonia. | 2.73e-06 | 2 | 58 | 2 | 38219297 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24507666 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24692096 | ||
| Pubmed | 6.44e-06 | 156 | 58 | 5 | 29961565 | ||
| Pubmed | 6.63e-06 | 22 | 58 | 3 | 14627618 | ||
| Pubmed | Vertebrate tropomyosin: distribution, properties and function. | 8.19e-06 | 3 | 58 | 2 | 11563548 | |
| Pubmed | Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. | 8.19e-06 | 3 | 58 | 2 | 8120097 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25586176 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 7568216 | ||
| Pubmed | h2-Calponin is regulated by mechanical tension and modifies the function of actin cytoskeleton. | 8.19e-06 | 3 | 58 | 2 | 16236705 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30977118 | ||
| Pubmed | Ca2+-dependent interaction of S100A2 with muscle and nonmuscle tropomyosins. | 1.64e-05 | 4 | 58 | 2 | 9092943 | |
| Pubmed | Degradation of cytoskeletal proteins by the human immunodeficiency virus type 1 protease. | 1.64e-05 | 4 | 58 | 2 | 1516138 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 9108196 | ||
| Pubmed | Nebulin interactions with actin and tropomyosin are altered by disease-causing mutations. | 2.72e-05 | 5 | 58 | 2 | 25110572 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 27421703 | ||
| Pubmed | Congenital Fiber-Type Disproportion – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 4.08e-05 | 6 | 58 | 2 | 20301436 | |
| Pubmed | Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. | 4.16e-05 | 40 | 58 | 3 | 20381070 | |
| Pubmed | HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress. | 4.49e-05 | 41 | 58 | 3 | 24614889 | |
| Pubmed | ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. | 5.71e-05 | 7 | 58 | 2 | 16728974 | |
| Pubmed | Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice. | 5.71e-05 | 7 | 58 | 2 | 19118250 | |
| Pubmed | STAM2, a new member of the STAM family, binding to the Janus kinases. | 7.60e-05 | 8 | 58 | 2 | 10899310 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 8.74e-05 | 269 | 58 | 5 | 29511261 | |
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 11782456 | ||
| Pubmed | Modulation of gene expression in the preimplantation mouse embryo by TGF-alpha and TGF-beta. | 1.22e-04 | 10 | 58 | 2 | 7654366 | |
| Pubmed | 1.42e-04 | 686 | 58 | 7 | 29987050 | ||
| Pubmed | Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening. | 1.48e-04 | 61 | 58 | 3 | 35205757 | |
| Pubmed | 1.58e-04 | 486 | 58 | 6 | 20936779 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 1.67e-04 | 1496 | 58 | 10 | 32877691 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 1.71e-04 | 949 | 58 | 8 | 36574265 | |
| Pubmed | 1.75e-04 | 312 | 58 | 5 | 37120454 | ||
| Pubmed | 1.78e-04 | 497 | 58 | 6 | 23414517 | ||
| Pubmed | 1.78e-04 | 12 | 58 | 2 | 12207328 | ||
| Pubmed | Vimentin is a novel AKT1 target mediating motility and invasion. | 1.78e-04 | 12 | 58 | 2 | 20856200 | |
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 1.78e-04 | 12 | 58 | 2 | 8618961 | |
| Pubmed | 1.78e-04 | 12 | 58 | 2 | 8424456 | ||
| Pubmed | 1.90e-04 | 503 | 58 | 6 | 36217030 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.97e-04 | 724 | 58 | 7 | 36232890 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.26e-04 | 989 | 58 | 8 | 36424410 | |
| Pubmed | 2.33e-04 | 332 | 58 | 5 | 37433992 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 2.52e-04 | 754 | 58 | 7 | 33060197 | |
| Pubmed | Proteomics of human umbilical vein endothelial cells applied to etoposide-induced apoptosis. | 2.62e-04 | 74 | 58 | 3 | 16130169 | |
| Pubmed | 3.10e-04 | 551 | 58 | 6 | 34728620 | ||
| Pubmed | 3.23e-04 | 16 | 58 | 2 | 16494860 | ||
| Pubmed | 3.66e-04 | 17 | 58 | 2 | 17634284 | ||
| Pubmed | Novel cell lines promote the discovery of genes involved in early heart development. | 4.11e-04 | 18 | 58 | 2 | 11437454 | |
| Pubmed | 5.09e-04 | 20 | 58 | 2 | 34497269 | ||
| Pubmed | 5.23e-04 | 222 | 58 | 4 | 35941108 | ||
| Pubmed | 5.69e-04 | 1431 | 58 | 9 | 37142655 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 6.09e-04 | 410 | 58 | 5 | 26949251 | |
| Pubmed | 6.18e-04 | 22 | 58 | 2 | 20111909 | ||
| Pubmed | 6.76e-04 | 23 | 58 | 2 | 18001291 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 6.79e-04 | 238 | 58 | 4 | 35864588 | |
| Pubmed | 7.57e-04 | 653 | 58 | 6 | 22586326 | ||
| Pubmed | 9.30e-04 | 259 | 58 | 4 | 31162944 | ||
| Pubmed | 1.03e-03 | 118 | 58 | 3 | 30979931 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.06e-03 | 268 | 58 | 4 | 33024031 | |
| Pubmed | Integrating genetic and network analysis to characterize genes related to mouse weight. | 1.08e-03 | 29 | 58 | 2 | 16934000 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.10e-03 | 1257 | 58 | 8 | 36526897 | |
| Pubmed | 1.14e-03 | 472 | 58 | 5 | 38943005 | ||
| Pubmed | 1.31e-03 | 32 | 58 | 2 | 21951318 | ||
| Pubmed | HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. | 1.31e-03 | 32 | 58 | 2 | 27114546 | |
| Pubmed | 1.32e-03 | 285 | 58 | 4 | 21423176 | ||
| Pubmed | Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia. | 1.45e-03 | 292 | 58 | 4 | 12819125 | |
| Pubmed | 1.55e-03 | 506 | 58 | 5 | 30890647 | ||
| Pubmed | Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins. | 1.57e-03 | 35 | 58 | 2 | 27812135 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.65e-03 | 1038 | 58 | 7 | 26673895 | |
| Interaction | PLCH2 interactions | 4.89e-06 | 12 | 58 | 3 | int:PLCH2 | |
| Interaction | FBXO22 interactions | 2.20e-05 | 540 | 58 | 9 | int:FBXO22 | |
| Cytoband | 5q12.3 | 2.37e-04 | 18 | 58 | 2 | 5q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q12 | 3.19e-03 | 66 | 58 | 2 | chr5q12 | |
| Cytoband | 1p13.3 | 3.49e-03 | 69 | 58 | 2 | 1p13.3 | |
| GeneFamily | Tropomyosins | 3.15e-08 | 4 | 37 | 3 | 777 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 6.82e-04 | 19 | 37 | 2 | 909 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.00e-03 | 23 | 37 | 2 | 1288 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CCNH FNBP1 HSP90B1 GPR19 STXBP3 GKAP1 PPIL4 UPF3A DIAPH3 PPWD1 | 1.59e-06 | 656 | 58 | 10 | M18979 |
| Coexpression | GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN | 3.62e-06 | 187 | 58 | 6 | M4905 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 5.55e-05 | 303 | 58 | 6 | M39040 | |
| Coexpression | ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1 | 6.16e-05 | 96 | 58 | 4 | M39216 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 7.20e-05 | 195 | 58 | 5 | M13736 | |
| Coexpression | ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR | 7.22e-05 | 100 | 58 | 4 | M39218 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP | 7.93e-05 | 199 | 58 | 5 | M4473 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_100 | 6.21e-05 | 81 | 56 | 4 | gudmap_kidney_adult_Mesangium_Meis_100 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#1_top-relative-expression-ranked_500 | 6.21e-05 | 81 | 56 | 4 | gudmap_kidney_adult_RenCorpuscGlomer_k1_500 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.24e-11 | 175 | 58 | 8 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.99e-09 | 188 | 58 | 7 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.18e-09 | 189 | 58 | 7 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.37e-09 | 190 | 58 | 7 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-09 | 193 | 58 | 7 | 7386fadc13a437f3b0c99b5d116cd3c5f893529c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-09 | 195 | 58 | 7 | 6e875c83f838241b5fcaf4a3249b1408d74521dc | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-07 | 175 | 58 | 6 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-07 | 175 | 58 | 6 | c94fb35bbac95123201ca87ca835aecaefc0c490 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-07 | 179 | 58 | 6 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.28e-07 | 180 | 58 | 6 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-07 | 189 | 58 | 6 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-07 | 190 | 58 | 6 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-07 | 190 | 58 | 6 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-07 | 190 | 58 | 6 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-07 | 196 | 58 | 6 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-06 | 170 | 58 | 5 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.26e-06 | 175 | 58 | 5 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-06 | 179 | 58 | 5 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 181 | 58 | 5 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 181 | 58 | 5 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.95e-06 | 182 | 58 | 5 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 185 | 58 | 5 | c4ef8d9f8b9769e887daac4efd9dc05738b28ae2 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 185 | 58 | 5 | 10ddf38d908525b4258f9d2da8be4c56ebc08ff4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.87e-06 | 190 | 58 | 5 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 190 | 58 | 5 | 1ab3f19f1ce9f58e5125135704d94655a2e330a0 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.87e-06 | 190 | 58 | 5 | 84fbd5664ec886120963d4f50dfa1fd1851d36c1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-06 | 191 | 58 | 5 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.12e-06 | 192 | 58 | 5 | 430ef714bf2544d32f3fd96a55af010f79aa9be0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.12e-06 | 192 | 58 | 5 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-06 | 193 | 58 | 5 | b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.25e-06 | 193 | 58 | 5 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.25e-06 | 193 | 58 | 5 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 5.66e-06 | 196 | 58 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.81e-06 | 197 | 58 | 5 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|erythropoietic / Lineage and Cell class | 6.10e-06 | 199 | 58 | 5 | 39c4adef3e02f948414f866aa22ac76f44b7b7db | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.25e-06 | 200 | 58 | 5 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 6.25e-06 | 200 | 58 | 5 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 6.25e-06 | 200 | 58 | 5 | be83f442179ba4217d12f0458059586ff3130991 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.36e-05 | 158 | 58 | 4 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.49e-05 | 159 | 58 | 4 | 7a5c94c87b73f928d4daee507f32cbe7d90e4478 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.63e-05 | 160 | 58 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 5.77e-05 | 161 | 58 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.91e-05 | 162 | 58 | 4 | c5eee02836efde2108534679850c28d2b2cfce3f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.05e-05 | 163 | 58 | 4 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 163 | 58 | 4 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.34e-05 | 165 | 58 | 4 | c042cde64b61ae195e1054f7b560151dabbfdf0d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.49e-05 | 166 | 58 | 4 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-05 | 166 | 58 | 4 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|metastatic_Brain / Location, Cell class and cell subclass | 6.49e-05 | 166 | 58 | 4 | 0da2c6ea1e62f1aafabafbbfbbcc6f7011739346 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.45e-05 | 172 | 58 | 4 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.79e-05 | 174 | 58 | 4 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.79e-05 | 174 | 58 | 4 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-05 | 174 | 58 | 4 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.79e-05 | 174 | 58 | 4 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.96e-05 | 175 | 58 | 4 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 176 | 58 | 4 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 176 | 58 | 4 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 176 | 58 | 4 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.32e-05 | 177 | 58 | 4 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 177 | 58 | 4 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.51e-05 | 178 | 58 | 4 | dbde3305e0c6a81593fe614e3f2e746b32cc16a7 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.69e-05 | 179 | 58 | 4 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.69e-05 | 179 | 58 | 4 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.88e-05 | 180 | 58 | 4 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.88e-05 | 180 | 58 | 4 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-05 | 181 | 58 | 4 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-05 | 181 | 58 | 4 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 9.47e-05 | 183 | 58 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 9.47e-05 | 183 | 58 | 4 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.47e-05 | 183 | 58 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.87e-05 | 185 | 58 | 4 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | BAL-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 9.87e-05 | 185 | 58 | 4 | e867ed55ab0df018f14bca824da09d36d83e12f9 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.03e-04 | 187 | 58 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | accb8a78b885703a27d4b560f0053f03d82ff3af | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-04 | 187 | 58 | 4 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.03e-04 | 187 | 58 | 4 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.05e-04 | 188 | 58 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 1.05e-04 | 188 | 58 | 4 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 188 | 58 | 4 | 15146fd2c5592ea84d20b1fdd172b39cd60b5bed | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 188 | 58 | 4 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 189 | 58 | 4 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.07e-04 | 189 | 58 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.07e-04 | 189 | 58 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 58 | 4 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 58 | 4 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 190 | 58 | 4 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 58 | 4 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 58 | 4 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 58 | 4 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 58 | 4 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.09e-04 | 190 | 58 | 4 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 58 | 4 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 190 | 58 | 4 | 7fec459cd2ad12c2923a03d098289337c0a4c1d3 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.09e-04 | 190 | 58 | 4 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 58 | 4 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 58 | 4 | ff7874cc005760a8f3b2e8072fbe418b6bfacaa8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 191 | 58 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 191 | 58 | 4 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-04 | 192 | 58 | 4 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.14e-04 | 192 | 58 | 4 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| Drug | conen | 5.07e-08 | 15 | 58 | 4 | CID000093117 | |
| Drug | amphidinolide D | 1.56e-07 | 5 | 58 | 3 | CID006439238 | |
| Drug | eudistomin M | 1.56e-07 | 5 | 58 | 3 | CID000145927 | |
| Drug | didansylcystine | 3.12e-07 | 6 | 58 | 3 | CID000167721 | |
| Drug | Topanol Ca | 5.45e-07 | 7 | 58 | 3 | CID000092905 | |
| Drug | TCNB | 5.82e-07 | 119 | 58 | 6 | CID000008330 | |
| Drug | 5-IAF | 7.14e-07 | 66 | 58 | 5 | CID000123822 | |
| Drug | CP-31 | 1.30e-06 | 9 | 58 | 3 | CID000452624 | |
| Drug | IASL | 1.86e-06 | 10 | 58 | 3 | CID002724305 | |
| Drug | AC1NSKFN | 2.10e-06 | 36 | 58 | 4 | CID005311324 | |
| Drug | AC1NRD2N | 3.40e-06 | 12 | 58 | 3 | CID005289322 | |
| Drug | TMBr-3 | 4.41e-06 | 13 | 58 | 3 | CID000518955 | |
| Drug | benzophenone-4-maleimide | 5.22e-06 | 45 | 58 | 4 | CID000146390 | |
| Drug | AC1MP21W | 5.60e-06 | 14 | 58 | 3 | CID003378340 | |
| Drug | goniodomin A | 5.60e-06 | 14 | 58 | 3 | CID006440832 | |
| Drug | A-G-T-C | 6.98e-06 | 15 | 58 | 3 | CID003037868 | |
| Drug | dansyl chloride | 8.21e-06 | 108 | 58 | 5 | CID000011801 | |
| Drug | DABMI | 1.04e-05 | 17 | 58 | 3 | CID000137371 | |
| Drug | acrylodan | 1.26e-05 | 56 | 58 | 4 | CID000104901 | |
| Drug | benzophenone-4-iodoacetamide | 1.48e-05 | 19 | 58 | 3 | CID000131289 | |
| Drug | AC1NRBPQ | 2.60e-05 | 137 | 58 | 5 | CID005288569 | |
| Drug | 7-azatryptophan | 2.68e-05 | 23 | 58 | 3 | CID005354789 | |
| Drug | dansylaziridine | 2.68e-05 | 23 | 58 | 3 | CID000104008 | |
| Drug | NSC 32050 | 5.47e-05 | 29 | 58 | 3 | CID000022780 | |
| Drug | N,N'-p-phenylenedimaleimide | 8.88e-05 | 34 | 58 | 3 | CID000076765 | |
| Drug | Dichloro-phen | 8.88e-05 | 34 | 58 | 3 | CID000003037 | |
| Drug | uranyl acetate | 1.06e-04 | 36 | 58 | 3 | CID000010915 | |
| Drug | S H Y | 1.24e-04 | 38 | 58 | 3 | CID004369485 | |
| Drug | AC1Q5G4B | 1.24e-04 | 38 | 58 | 3 | CID000207983 | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 4467_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 4523_DN | |
| Drug | 3-(2-carboxyindol-3-yl)propionic acid | 1.80e-04 | 43 | 58 | 3 | CID000169313 | |
| Drug | silaned | 1.80e-04 | 43 | 58 | 3 | CID006335299 | |
| Drug | ethylene glycol tetraacetic acid | 1.93e-04 | 44 | 58 | 3 | CID000006207 | |
| Drug | LS109 | 2.16e-04 | 338 | 58 | 6 | CID000019920 | |
| Drug | pemoline | 2.35e-04 | 47 | 58 | 3 | CID000004723 | |
| Disease | Nemaline Myopathy, Childhood Onset | 2.51e-07 | 7 | 58 | 3 | C0546125 | |
| Disease | Myopathies, Nemaline | 4.01e-07 | 8 | 58 | 3 | C0206157 | |
| Disease | Nemaline myopathy | 4.01e-07 | 8 | 58 | 3 | cv:C0206157 | |
| Disease | Congenital myopathy (disorder) | 1.57e-06 | 12 | 58 | 3 | C0270960 | |
| Disease | Cap Myopathy | 1.14e-05 | 3 | 58 | 2 | C3710589 | |
| Disease | Inflammatory Myofibroblastic Tumor | 5.67e-05 | 6 | 58 | 2 | C0334121 | |
| Disease | Congenital myopathy with fiber type disproportion | 5.67e-05 | 6 | 58 | 2 | cv:C0546264 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 2.92e-04 | 13 | 58 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 2.92e-04 | 13 | 58 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 2.92e-04 | 13 | 58 | 2 | C0410203 | |
| Disease | gamma-glutamylleucine measurement | 2.92e-04 | 13 | 58 | 2 | EFO_0021140 | |
| Disease | Congenital Structural Myopathy | 2.92e-04 | 13 | 58 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, 1 | 2.92e-04 | 13 | 58 | 2 | C4551952 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 3.40e-04 | 14 | 58 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 3.40e-04 | 14 | 58 | 2 | C0410207 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 3.92e-04 | 15 | 58 | 2 | C3645536 | |
| Disease | juvenile idiopathic arthritis | 4.23e-04 | 74 | 58 | 3 | EFO_0002609 | |
| Disease | macula measurement | 5.28e-04 | 189 | 58 | 4 | EFO_0008375 | |
| Disease | Congenital Fiber Type Disproportion | 5.69e-04 | 18 | 58 | 2 | C0546264 | |
| Disease | chronotype measurement | 1.66e-03 | 882 | 58 | 7 | EFO_0008328 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKKRKGYEDDDYVSK | 291 | P51946 | |
| GYEDDDYVSKKSKHE | 296 | P51946 | |
| KDSIYDSFDREAKEK | 386 | Q15760 | |
| LEKAKEKYGVDDYSV | 1666 | Q99758 | |
| LSKLEYEEHKKEYED | 136 | Q5VSY0 | |
| YDAYVEELEKQEKTK | 231 | Q9UI46 | |
| EEKASELYKKFEKEF | 506 | Q9NSV4 | |
| DYAYNLEKKSVLDKD | 181 | Q5JU67 | |
| TDMKYLLYEDEKDFK | 346 | Q8IWF9 | |
| KAIETDKEYYTVKDD | 1026 | P23458 | |
| YTKSDFKEYEKEQDK | 331 | Q8WUA2 | |
| ENYKEDKYSEKSSGA | 471 | Q9P2G4 | |
| VSNKAYEDAEAKAKY | 331 | Q13976 | |
| YEDAEAKAKYEAEAA | 336 | Q13976 | |
| NLKKDEEDTKFADYE | 1156 | Q9ULI0 | |
| AERSYYLEKAKLEKE | 86 | Q12766 | |
| DELMSEEAYEKYIKS | 156 | P23434 | |
| KAYSNIKDYIDEAEK | 1926 | P24043 | |
| ESTVYDDYKFVTKKD | 366 | Q9BSC4 | |
| KDVYEEFDEKIATKY | 411 | P09884 | |
| KEIDDVYEKYKKEDD | 61 | Q9H160 | |
| KYDIYEKQTKEETDS | 401 | P78552 | |
| PSKEVEEDEYKAFYK | 346 | P14625 | |
| LKDEETRKDYDYMLD | 111 | Q9H1X3 | |
| ESYEIYVEDLKKDEK | 141 | O95760 | |
| EDSDYDKLSDMVKYL | 851 | A4D2P6 | |
| EEKTKEADEYLDKYC | 2851 | P49454 | |
| KKNSKEEEEYKYTSC | 56 | Q96RU3 | |
| DFSTKDYLKDNLDKY | 536 | Q7Z7M9 | |
| TEDLYEVDKLKKECY | 786 | Q5T1B0 | |
| YAEYSTKKLKDVLEE | 21 | Q9Y6T7 | |
| AYSKCKEYSDDKVQL | 71 | Q8WYH8 | |
| DDSDFDEKAKLKYYK | 366 | Q9NQZ2 | |
| STEKLEKEDENYYQK | 176 | Q8IVI9 | |
| YKYSKVNKEEETDEN | 2351 | P11717 | |
| VDEVDYKTAEEKYIK | 671 | Q2TAK8 | |
| EKSDDNSYDEKYLIA | 256 | P49591 | |
| KLDPYDSSEDDKEYV | 111 | O43236 | |
| EQKEYENRDYKDFTK | 976 | Q9UMZ2 | |
| EYKKFLETYCVEEEK | 176 | Q9H1J1 | |
| EYKTDTDLYEFAKCK | 266 | Q96BP3 | |
| NDTYKYKTDGKEKEA | 266 | O00186 | |
| EIFGYDRKKYKDESD | 621 | Q68D10 | |
| KKEDEKAAAEIYEEF | 106 | O15042 | |
| EYDTKEVKYCTFSKD | 146 | Q8NHS4 | |
| DFIDSLEKTDDDKYK | 226 | Q9BYT8 | |
| DTEYTLYKKEEEIKT | 986 | Q9BXU1 | |
| EKEKDRYFSLSDKDA | 126 | Q96BR9 | |
| YEKVIEDFDKDQADY | 606 | Q9H2G4 | |
| LEAASEKYSEKEDKY | 171 | P67936 | |
| EKYSEKEDKYEEEIK | 176 | P67936 | |
| RDESYYEKDSEKKGI | 466 | Q9Y6Q2 | |
| YEKDSEKKGIDILDY | 471 | Q9Y6Q2 | |
| EEYKLKEYSKSMDES | 1176 | Q96PV0 | |
| KEYTEYNEEKKKEAE | 116 | O95630 | |
| EYIKKGKEDYEESHQ | 1621 | P53804 | |
| AEKEYDKAVQSYKDV | 901 | Q8NDW8 | |
| ADKYSTKEDKYEEEI | 211 | P07951 | |
| TISYSKYKEDLTEDK | 566 | O95932 | |
| QAEKYSQKEDKYEEE | 211 | P06753 | |
| VVEDYKSKYEDEINK | 246 | Q7Z794 | |
| SDKSYKAEYEEDKGK | 701 | P20929 | |
| QSDREYKKDYEKTKS | 1121 | P20929 |